Prof. Dr. Karin Schumacher is a Professor of Plant Developmental Biology at Heidelberg University and currently serves as Vice-Rector for Quality Development and Sustainability. Her research focuses on plant cell biology, particularly vacuole dynamics, ion homeostasis, and membrane trafficking in Arabidopsis. She leads the Cell Biology Research Group at the Centre for Organismal Studies (COS) and has held leadership roles such as Dean of the Faculty of Biosciences. Her work integrates computational modeling with experimental approaches to study plant growth and stress responses. Dr. Schumacher's academic career includes a Doctorate from the University of Cologne and a Habilitation from the University of Tübingen. She has held professorial positions since 2007 and contributed to advancements in understanding plant membrane systems, including V-ATPase function and calcium signaling. Her research publications emphasize vacuolar ion transport, autophagy mechanisms, and plant stress physiology. Her administrative roles include enhancing early career researcher support and promoting sustainability in university operations. She is an active member of scientific societies like the German Botanical Society and serves on editorial boards such as Plant Cell . Her interdisciplinary work bridges cell biology, molecular genetics, and systems-level plant physiology.
Chi (Jesse) Zhang is a Research Professor at Purdue University's Department of Chemistry, leading the Zhang Research Group. His work focuses on developing novel optical spectroscopy, imaging, and opto-control technologies to study chemical processes in living systems. He has pioneered techniques like Real-Time Precision Opto-Control (RPOC) and applies them to biomedical problems, including cancer metabolism and neurodegenerative diseases. His lab collaborates with institutions like Merck and has been recognized with awards such as the Astronaut Scholarship and Alice Watson Kramer Award. Education details are not explicitly provided, but his postdoctoral research at the Beckman Institute (2018–2020) indicates prior training in advanced scientific technology. His research integrates optical engineering with biological systems, emphasizing label-free imaging and real-time manipulation of cellular components. Key achievements include over 50 peer-reviewed publications and the development of the photokinesis technology platform (http://www.photokinesis.tech). His group hosts an active wet lab with projects ranging from lipid metabolism studies to optical device innovation. Recent milestones include successful student defenses, conference presentations, and impactful publications in ACS Photonics , Anal. Chem , and npj Imaging .
Prof. Dr. Marek Basler is an Associate Professor of Infection Biology at the Biozentrum, University of Basel , leading a research group focused on the Type VI Secretion System (T6SS) in bacterial pathogens. His work bridges structural biology, molecular microbiology, and computational analysis to unravel the mechanisms of this contractile nanomachine. PhD in Microbiology (2007, Institute of Microbiology, CAS, Prague) Postdoctoral Fellow (2007–2013, Harvard Medical School) Assistant Professor (2013–2018) and Associate Professor (since 2018) at Biozentrum His research explores the structure, assembly, and therapeutic potential of the T6SS, a critical virulence factor in pathogens like Pseudomonas aeruginosa . Key themes include bacterial defense strategies , intermicrobial competition , and host-pathogen interactions . Recent projects highlight T6SS roles in antibiotic resistance and horizontal gene transfer . The most recent publications (2025–2024) reveal novel insights into T6SS activation by environmental stress , toxin diversity , and host cell targeting . Trends span microbial ecology , nanomachine dynamics , and computational modeling of bacterial interactions. Scientific Awards : EMBO Membership (2023) ERC Consolidator Grant (2019) EMBO Gold Medal (2018) Friedrich Miescher Award (2018) EMBO Young Investigator (2015) His lab (Basler Lab) utilizes state-of-the-art microscopy , biochemical techniques , and live-cell simulations (e.g., BacFighT6 ). Collaborations span institutions like Harvard Medical School and NCCR-AntiResist , with future work targeting antibacterial therapies .
Professor Luke Chamberlain is a leading researcher at the Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, where he investigates the role of protein S-acylation in health and disease. His work bridges fundamental biochemistry with therapeutic discovery, focusing on the zDHHC family of enzymes and their impact on cellular signaling, membrane trafficking, and disease mechanisms. Education: PhD in Role of Cysteine-String Protein in Regulated Exocytosis, University of Liverpool (1998) BSc in Microbiology, University of Edinburgh (1994) His research is primarily focused on protein S-acylation (palmitoylation) , a reversible lipid modification that regulates protein localization, stability, and function. He explores how defects in this process contribute to neurodegenerative diseases, cancer, and diabetes. His lab employs advanced techniques such as click chemistry, confocal microscopy, proteomics, and behavioral analyses to dissect molecular mechanisms. The recent publications highlight trends in understanding substrate specificity of zDHHC enzymes , development of inhibitors , and the regulatory role of S-acylation in metabolic and neurological pathways . His work increasingly emphasizes chemical biology approaches to target S-acylation therapeutically. Scientific Awards: No awards explicitly mentioned in the text. Prof. Chamberlain actively mentors postdoctoral researchers and prospective PhD students, offering support for fellowship applications. He is Principal Investigator on multiple grants, including an integrated analysis of S-acylation dynamics (BBSRC-funded) and a Strathclyde-led network with Thailand. His professional activities include serving as an examiner for PhD theses, chairing international conferences such as the FASEB meeting on Protein Lipidation, and participating in research visits to institutions like Tsinghua and Peking University. Labs and Facilities: His research group utilizes the Leica SP8 Confocal Microscope facility at the Strathclyde Institute, enabling high-resolution imaging of protein localization and dynamics in live and fixed cells.
George M. Church is a Professor of Genetics at Harvard Medical School and affiliated with MIT, where he directs PersonalGenomes.org, providing open-access genomic, environmental and trait data. His laboratory focuses on transformative technologies for reading and writing 3D/4D biological structures with attention to ethics, safety, and equitable access. Church has co-initiated major scientific initiatives including the BRAIN Initiative (2011) and multiple Genome Projects (GP-Read-1984, GP-Write-2016, PGP-2005). Church's research spans multiple cutting-edge domains including genome engineering, synthetic biology, aging reversal, and space genetics. His lab pioneered foundational methods for direct genome sequencing, molecular multiplexing and barcoding in 1984, leading to the first genome sequence in 1994. His innovations contributed to nearly all next-generation DNA sequencing methods and companies. Current research directions include machine learning for protein engineering, tissue reprogramming, organoids, gene therapy, and in situ 3D DNA/RNA/protein imaging. His work bridges fundamental biology with therapeutic applications across diverse fields from Alzheimer's disease to de-extinction biology. Church's recent publications reveal a remarkable breadth of scientific inquiry, spanning from fundamental genome editing techniques to applications in aging research, neuroscience, and space biology. His work increasingly integrates artificial intelligence with biological systems, as seen in papers on machine-guided cell-fate engineering and automation of systematic reviews with large language models. His research maintains a strong translational focus, with numerous papers addressing therapeutic applications in cancer immunotherapy, gene therapy, and diagnostics. The consistent theme across his diverse publications is the development and application of transformative technologies to address fundamental biological questions and medical challenges. National Academy of Sciences (NAS) membership National Academy of Engineering (NAE) membership Franklin Bower Laureate for Achievement in Science Co-initiator of the BRAIN Initiative (2011) Director of multiple NIH Centers for Excellence in Genomic Science (2004-2020) Church directs numerous research centers including the NIH-CEGS, Personal Genome Project (PGP), Lipper Center for Computational Genetics, and Wyss Institute Synthetic Biology center. His laboratory has trained PhD students across multiple Harvard and MIT programs including Biophysics, BBS, Biomedical Informatics, ChemBio, Chemistry, SSQB, MCO, Virology, HST, EE/CS, Physics and Applied Math. His commercial impact is extensive through companies spanning medical diagnostics (Knome/PierianDx, Alacris, Nebula, Veritas) and synthetic biology/therapeutics (AbVitro/Juno, Gen9/enEvolv/Zymergen/Warpdrive/Gingko, Editas, Egenesis). Church also pioneered new privacy, biosafety, ELSI, environmental and biosecurity policies. The Church Lab operates across multiple research domains including molecular multiplexing, next-generation sequencing, nanopore technology, and genome engineering. The lab maintains strong connections with the Personal Genome Project, Wyss Institute, and multiple commercial ventures. Current research directions include the Spatial Atlas of Human Anatomy (SAHA), human skin rejuvenation via mRNA, and space genetics research through the Consortium for Space Genetics and BioAstra. The lab's mission focuses on transformative technologies for reading and writing 3D/4D structures at any scale, inspired by but not limited by biology.
Sophia Lunt is a Professor in the Department of Biochemistry & Molecular Biology and Chemical Engineering & Materials Science at Michigan State University , where she has been since 2015 (Assistant Professor 2015-2021, Associate Professor 2021-2025, Professor 2025-present). She leads the Lunt Lab , focusing on cancer metabolism , particularly metabolic reprogramming in tumor proliferation, heterogeneity, and metastasis . Her work combines mass spectrometry , genetic cancer models , cell biology , and fluorescent agents to develop targeted cancer therapies . Ph.D. (2010) & B.S. (2005) in Chemistry Postdoctoral Fellow at MIT (2010-2015) NSF CAREER awardee (2019) 20+ peer-reviewed publications since 2007 Research Focus : Cancer metabolism (Warburg effect, PHGDH heterogeneity, TIGAR regulation) Photodynamic therapy (counterion-tuned agents, metal halide nanoclusters) Metabolomics (tumor-immune interactions, microbiome effects) Selected Scientific Awards : 2022 MSU College of Natural Science Teacher-Scholar Award 2022 MSU BMB Teaching Award 2020 MANA Young Investigator Award 2019 NSF CAREER & METAvivor Early Career Investigator Awards Her teaching includes BMB 101: Frontiers in Biochemistry (curriculum overhaul for freshman success) and BMB 461: Advanced Biochemistry I , covering metabolic regulation and pathways.
Kenneth A. Barbee is a Professor and Senior Associate Dean for Research at the School of Biomedical Engineering, Science and Health Systems at Drexel University . His research focuses on cellular biomechanics, particularly the response of neural and vascular tissues to mechanical loading and trauma. Education : PhD in Bioengineering from University of Pennsylvania (1991), MS in Bioengineering from University of Pennsylvania (1988), BS in Engineering Science and Mechanics from University of Tennessee (1986) Barbee's research explores mechanotransduction in the cardiovascular system, including how endothelial cells respond to shear stress and vascular smooth muscle cells adapt to cyclic stretching. He employs advanced techniques such as Atomic Force Microscopy (AFM) , Computational Fluid Dynamics (CFD) , and fluorescence microscopy in his work. His studies also address cellular injury criteria under traumatic loading conditions to aid protective equipment design and therapeutic evaluation. Publications highlight his contributions to understanding shear stress gradients in atherogenesis, calcium signaling in endothelial cells, and deformation models for vascular smooth muscle. These works span disciplines including biomechanics , cell biology , and bioengineering .
Kyu Young Han is an Associate Professor in Optics & Photonics at CREOL, The College of Optics and Photonics, University of Central Florida. His research focuses on developing advanced optical tools for biological and neuroscience applications, including super-resolution imaging (STED/GSD microscopy), label-free single-molecule imaging, and novel microscopy techniques. He holds a patent commercialized by Leica Microsystems and has received the 2020 NIH Maximizing Investigators’ Research Award (MIRA). Education: BS and PhD in Chemistry from Seoul National University (2004 and 2010). Postdoctoral work at the University of Illinois (2011–2016) and Max Planck Institute for Biophysical Chemistry (Germany), specializing in optical microscopy innovation. Research interests emphasize nanoscopy, biophotonics, and interdisciplinary applications in cell biology. His group explores nuclear structure in mammalian cells, DNA-protein interactions, and RNA imaging in live cells. Recent work includes optimizing imaging techniques like TIRF microscopy and integrating deep learning for faster, less damaging STED imaging. Publications span cutting-edge advancements in microscopy resolution, photobleaching reduction, and single-molecule analysis. He advises multiple PhD students and collaborates across disciplines, contributing to Parkinson’s disease research through imaging-driven molecular studies.
Ming Lei is a Professor of Physiology and Pharmacology at the University of Oxford. His research focuses on cardiac electrophysiology, signal transduction, and molecular mechanisms of arrhythmias. He leads the Lei Group , also known as the Cardiac Signalling Group , which explores novel therapeutic targets for cardiovascular diseases. Education: BM, MD, D.Phil Professional Recognition: Fellow of the Royal Society of Biology (FRSB) Recent publications highlight his work on: PAK Kinases as targets for arrhythmias Anti-arrhythmic drug classification and clinical applications Isoform-specific glycosylation of ion channels Optical mapping techniques in preclinical cardiac models Stem cell-derived cardiomyocytes for studying atrial function His research trends emphasize molecular mechanisms of cardiac dysfunction, kinase modulation, and advanced imaging methodologies. The Lei Group collaborates on projects involving genetic models (e.g., RyR2 knock-in mice) and cellular interactions (e.g., myofibroblast-cardiomyocyte crosstalk). Key subfields include signal transduction , lysosomal pathways , ion channel regulation , cardiac hypertrophy , electrophysiological imaging , and stem cell applications .
Jean Fan, PhD is an Assistant Professor of Biomedical Engineering at Johns Hopkins University, affiliated with the Center for Computational Biology and Institute for Computational Medicine. Her research focuses on developing machine learning methods to analyze spatially resolved and single-cell omics data. Her team, the JEFworks Lab, creates open-source tools for analyzing high-dimensional biological data to understand cellular identity, tissue organization, and disease progression. Dr. Fan's work bridges computational biology with clinical applications, particularly in leukemia and pediatric brain cancers. Education: BS in Biomedical Engineering & Applied Math from Johns Hopkins (2013); PhD in Bioinformatics from Harvard Medical School (2018); Postdoc in Chemical Biology/Physics at Harvard (2018–2020) under Xiaowei Zhuang, focusing on spatial transcriptomics. Research emphasizes spatial genomics and computational tool development, with key contributions to spatial alignment algorithms (STalign), normalization techniques, and cell-type deconvolution methods. Her lab's work has advanced understanding of kidney ischemic injury, glioblastoma spatial dynamics, and CLL pathogenesis. Awards include Forbes 30 Under 30, NSF CAREER Award, and 2025 PECASE. She founded CuSTEMized, a nonprofit providing STEM storybooks for girls. Recent collaborative projects include HuBMAP 3D reference atlas construction and Discovery Award-funded interdisciplinary initiatives. Labs/Teams: JEFworks Lab (primary); active collaborations with Dana-Farber Cancer Institute and Harvard Medical School. Current efforts focus on spatially resolved multi-omic integration and clinical translation of computational tools.
Xue Han is a Professor of Biomedical Engineering at Boston University (BU), affiliated with the Han Lab. His primary academic appointment is in the Biomedical Engineering department, with additional affiliations in Neuroscience & Neuroengineering, and Photonics & Optical Systems. He holds a PhD in Physiology from the University of Wisconsin-Madison and a B.S. in Biophysics from Beijing University, China. Dr. Han’s research focuses on addressing unmet medical needs in brain disorders by developing novel neuromodulation therapies. His work combines genetic, molecular, pharmacological, optical, and electrical tools to study neural circuit dynamics, with a particular emphasis on optogenetics and optical neural modulation. Key projects include pioneering light-based neuron silencing techniques and pre-clinical testing of neurotechnologies like transcranial ultrasound stimulation. His lab investigates how neural synchrony contributes to cognition and pathology, aiming to link neural activity to behaviors like movement, attention, and decision-making. His recent publications emphasize high-frequency electrical stimulation effects, membrane voltage imaging, and the impact of neuromodulation on brain rhythms. Notable themes include the role of PV neurons in cortical coding, ultrasound-based neuron activation, and the interplay between neural oscillations and disease states. While no formal awards are listed, his prolific output highlights contributions to neurotechnology and systems neuroscience. Dr. Han’s lab develops advanced imaging tools like targeted-illumination confocal microscopy (TICO) and collaborates on projects involving exosome-mediated therapies and brain-computer interfaces. Ongoing work explores translational applications of neurophotonic tools and the mechanistic basis of neuromodulation therapies for disorders like Parkinson’s and epilepsy.
Dr. Christopher R. Jones is a Senior Lecturer in the School of Physical and Chemical Sciences at Queen Mary University of London. He holds a MSci in Natural Sciences from the University of Cambridge (2005) and a PhD in Organic Chemistry under Prof. Martin D. Smith (2009). He was a Junior Research Fellow at the University of Oxford (2009–2013) and joined Queen Mary as a Ramsay Memorial Research Fellow in 2013. He received an EPSRC Early Career Fellowship in 2015. His research focuses on developing sustainable organic synthesis methodologies, particularly leveraging aryne chemistry and functional carbon nanomaterials. Key areas include aryne-mediated C(sp³)-H bond functionalization, biologically active heterocycles, and applications in green chemistry. Current research grants include EPSRC funding for catalytic reactive intermediate studies (2015–2021), RSC grants for aryne synthesis (2018–2025), and a PAK UK Education Gateway Mobility Partnership (2023–2024). Dr. Jones supervises multiple PhD students, including co-supervision with Prof. Stellios Arseniyadis. His work has led to publications in high-impact journals like Nature Chemistry and Chemical Science , emphasizing innovations in organic synthesis and materials chemistry.
Minoru Koyama is an Assistant Professor in the Department of Cell & Systems Biology at the University of Toronto Scarborough (UTSC). His research focuses on understanding the neural circuit mechanisms underlying behavioral development, particularly in zebrafish models. He employs advanced techniques such as optogenetics, voltage imaging, and CRISPR-based methods to study circuit maturation in the hindbrain and spinal cord. Education: Koyama holds a Ph.D. (2006), M.Sc. (2002), and B.Sc. (2000) in Biological Sciences from the University of Tokyo. Research Interests: His work investigates how neural circuits mature post-birth and contribute to complex behaviors, with applications to developmental brain disorders. His lab uses zebrafish as a model system, combining optics, genetics, and machine learning for behavioral analysis. Key projects include studying motor coordination development and refining imaging techniques like multi-plane microscopy and voltage indicators. Publications Highlight: Koyama’s recent work includes innovations in microscopy (e.g., HiLo speckle illumination) and genetic tools (e.g., TEMPO lineage tracing). These advancements enable precise observation of neural circuits and cellular dynamics. Lab & Recruitment: The Koyama Lab actively recruits graduate students and postdoctoral researchers. No specific grants are detailed, but his work reflects broad interdisciplinary collaborations in neuroscience and biotechnology. Labs/Teams: His lab focuses on developmental neurobiology, leveraging cutting-edge imaging and genetic engineering to explore neural circuit function across vertebrate development.
David Agard is a Professor in the Department of Biochemistry and Biophysics at the University of California San Francisco (UCSF), where he leads a research group focused on uncovering the structural basis of biological function at the molecular and cellular levels. His lab specializes in advanced cryo-electron microscopy (cryo-EM) and fluorescence light microscopy, developing novel imaging technologies to study dynamic cellular processes. His research interests span structural biology , molecular chaperone function (particularly Hsp90 and its role in disease), microtubule nucleation , centrosome and cilium structure , and the structure of phage-encoded tubulins . He is deeply involved in methodological innovations in cryo-EM data processing , including deconvolution, heterogeneous reconstruction, and tomography, enabling atomic-level insights into complex biological systems. Recent publications highlight his lab’s work on the structural mechanisms of Hsp90-client regulation, microtubule organization, phage nucleus formation, and high-resolution imaging techniques using functionalized graphene-oxide grids. His work increasingly integrates AI-driven structural modeling and in situ approaches to understand macromolecular complexes in their native cellular context. Dr. Agard has made seminal contributions to understanding the ATPase cycle of Hsp90, the architecture of the gamma-tubulin complex, and the structural dynamics of viral and cellular tubulins. His research bridges biochemistry, biophysics, and cell biology, with implications for cancer, neurodegeneration, and antimicrobial strategies.
Roy Golsteyn is a Professor at the University of Lethbridge , affiliated with the Biological Sciences Department . Holding a PhD in Biochemistry from the University of Cambridge, his research focuses on natural products from Canadian plants, particularly through the Prairie to Pharmacy Program , which integrates ethnobotany , imaging technology , and partnerships with First Nation communities . Degrees: PhD Biochemistry (Cambridge), MSc Medical Biochemistry (Calgary), BSc Biological Sciences (Lethbridge) His work explores how natural compounds affect cell cycle regulation , with a focus on mitosis inhibition , genomic instability , and apoptosis in cancer cells. Recent studies include ruthenium complexes targeting cancer pathways and sesquiterpene lactones from prairie flora. Key grants include funding from NSERC , the Canada Foundation for Innovation , and Power Corp. Canada . He has been featured in media outlets like CBC Radio and CTV for his collaborative research and philanthropy. Awards: Government Award, France (2000)
